[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
What You Need to Know About MRD: The Basics
What You Need to Know About MRD: The Basics image
Adult AML Chapter
event Sep 14, 2023 / 04:30PM - 05:30PM EDT

Event Description

What is MRD, how do we test for it and why is this an important test for AML patients? When should this testing take place during the course of your AML treatment? Can MRD testing be used to personalize and optimize your care? Learn all of this information and more from AML expert, Dr. Tian Zhang. Come with your questions!

Schedule & Agenda

The panelist Katie Braswell
Introduction
4:30 PM
Katie Braswell

Katie introduces the event's agenda and featured speaker Dr. Tian Zhang.

The panelist Tian Zhang, MD
Presentation
4:35 PM
Tian Zhang, MD

Dr. Zhang shares important information AML patients should know about MRD and MRD testing.

The panelist Audience
Questions and Answers
5:05 PM
Audience

Type your questions in the chat and Dr. Zhang will answer them!

Speakers & Moderators

The panelist Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.

Read Bio
The panelist Tian Zhang, MD
Tian Zhang, MD
Stanford, CA

Dr. Zhang is a hematologist oncologist and assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology. In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. Dr. Zhang's lab is currently studying a novel and noninvasive way of detecting measurable residual disease (MRD) in AML patients throughout their disease course.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube